1-3 of 3
cyclins
Close
Sort by
Journal Articles

Evaluation of cyclin A1–specific T cells as a potential treatment for acute myeloid leukemia

Wingchi K. Leung, Aster Workineh, Shivani Mukhi, Ifigeneia Tzannou, Daniel Brenner, Norihiro Watanabe, Ann M. Leen, Premal Lulla
Journal: Blood Advances
Blood Adv (2020) 4 (2): 387–397.
https://doi.org/10.1182/bloodadvances.2019000715
Published: 2020
Includes: Supplemental data
Journal Articles

Cells of adult T-cell leukemia evade HTLV-1 Tax/NF-κB hyperactivation–induced senescence

Abigail M. Druck Shudofsky, Chou-Zen Giam
Journal: Blood Advances
Blood Adv (2019) 3 (4): 564–569.
https://doi.org/10.1182/bloodadvances.2018029322
Published: 2019
Journal Articles

Recurrent CCND3 mutations in MLL -rearranged acute myeloid leukemia

Clinical Trials & Observations
Hidemasa Matsuo, Kenichi Yoshida, Kazutaka Fukumura, Kana Nakatani, Yuki Noguchi, Saho Takasaki, Mina Noura, Yusuke Shiozawa, Yuichi Shiraishi, Kenichi Chiba, Hiroko Tanaka, Ai Okada, Yasuhito Nannya, June Takeda, Hiroo Ueno, Norio Shiba, Genki Yamato, Hiroshi Handa, Yuichiro Ono, Nobuhiro Hiramoto, Takayuki Ishikawa, Kensuke Usuki, Ken Ishiyama, Shuichi Miyawaki, Hidehiro Itonaga, Yasushi Miyazaki, Machiko Kawamura, Hiroki Yamaguchi, Nobutaka Kiyokawa, Daisuke Tomizawa, Takashi Taga, Akio Tawa, Yasuhide Hayashi, Hiroyuki Mano, Satoru Miyano, Yasuhiko Kamikubo, Seishi Ogawa, Souichi Adachi
Journal: Blood Advances
Blood Adv (2018) 2 (21): 2879–2889.
https://doi.org/10.1182/bloodadvances.2018019398
Published: 2018
Includes: Supplemental data